Loading data
SRXHNYSE
| Unit: USD | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | 6.53 m USD | 34.98 m USD | — | 38.59 m USD | — |
| Cost of revenue | 5.01 m USD | 21.99 m USD | — | 26.8 m USD | — |
| Gross profit | 1.53 m USD | 12.99 m USD | — | 11.8 m USD | — |
| Research and development expense | — | 100 k USD | — | 100 k USD | — |
| Selling, general and administrative expense | 12.93 m USD | 18.96 m USD | — | 24.44 m USD | — |
| Operating profit | -11.41 m USD | -5.97 m USD | — | -21.18 m USD | — |
| Interest expense | 628 k USD | 467 k USD | — | 1.35 m USD | — |
| Profit before tax | -8.64 m USD | -159 k USD | — | -22.77 m USD | — |
| Income tax expense | — | 9 k USD | -1.24 m USD | 2 k USD | 267 k USD |
| Net income (reported basis) | -45.01 m USD | -168 k USD | -43.05 m USD | -22.77 m USD | — |
| Net income attributable to common shareholders | -45.01 m USD | -168 k USD | — | -22.77 m USD | — |
| Basic earnings per share | -2.13 USD/share | -0.1 USD/share | -1.95 USD/share | -32.29 USD/share | — |
| Diluted earnings per share | -2.13 USD/share | -0.1 USD/share | -1.95 USD/share | -32.29 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.